Insider · CIK 0001234864

AFTING ERNST-GUENTER

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001234864

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-11	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2015-02-19	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	—	—	6,000
2014-02-06	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+4,640 sh	—	—	4,640
2013-12-11	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−2,100 sh	$37.91	−$79.6K	17,287
2013-12-11	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−7,100 sh	$37.20	−$264K	19,387
2013-12-11	ENTAENANTA PHARMACEUTICALS INCS Sale	Director	SSale	−5,800 sh	$36.38	−$211K	26,487
2013-10-29	Sorrento Therapeutics, Inc.Stock OptionsA Award	Director	AAward	+9,000 sh	—	—	26,600
2013-06-11	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series C Convertible Preferred StockC Conversion	Director	CConversion	−2,906 sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series G-2 Convertible Preferred StockC Conversion	Director	CConversion	−48.3K sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series A Convertible Preferred StockC Conversion	Director	CConversion	−10K sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series B Convertible Preferred StockC Conversion	Director	CConversion	−10K sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INC · Series E Convertible Preferred StockC Conversion	Director	CConversion	−320 sh	—	—	0
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	Director	CConversion	+2,320 sh	—	—	17,981
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	Director	CConversion	+2,320 sh	—	—	20,301
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	Director	CConversion	+674 sh	—	—	20,975
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	Director	CConversion	+97 sh	—	—	21,072
2013-03-26	ENTAENANTA PHARMACEUTICALS INCC Conversion	Director	CConversion	+11.2K sh	—	—	32,287
2013-03-20	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director	AAward	+5,800 sh	—	—	5,800
2013-01-02	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+16.2K sh	—	—	16,190
2012-10-17	Sorrento Therapeutics, Inc.Non-qualified stock optionA Award	Director	AAward	+400K sh	—	—	400,000
2012-06-11	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-01-03	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+9,375 sh	—	—	9,375
2011-06-15	SEQUENOM INCNon-Qualified Stock Option(right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-01-03	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+5,556 sh	—	—	5,556
2010-12-21	Sorrento Therapeutics, Inc.P Purchase	Director	PPurchase	+360K sh	$0.14	+$50.4K	917,930
2010-11-29	Sorrento Therapeutics, Inc.Non-qualified stock optionsA Award	Director	AAward	+27.5K sh	—	—	75,000
2010-06-14	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2010-02-05	Sorrento Therapeutics, Inc.Non-qualified stock optionsA Award	Director	AAward	+7,500 sh	—	—	47,500
2010-01-04	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,752
2009-09-21	Sorrento Therapeutics, Inc.Non-Employee Director Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2009-05-12	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2008-12-16	SEQUENOM INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2008-12-16	SEQUENOM INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−40K sh	—	—	0
2008-12-16	SEQUENOM INCM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$4.58	+$91.6K	97,499
2008-12-16	SEQUENOM INCM Exercise/Conversion	Director	MExercise/Conversion	+40K sh	$1.87	+$74.8K	77,499
2008-05-30	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2007-06-22	SEQUENOM INCStock Option (Right to BuyA Award	Director	AAward	+20K sh	—	—	20,000
2006-06-06	SEQUENOM INCStock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2005-06-17	SEQUENOM INCNon-Qualified Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Feb 124
ENANTA PHARMACEUTICALS INC0000908662-16-000456
SEC(opens sec.gov)
Feb 204
ENANTA PHARMACEUTICALS INC0000908662-15-000079
SEC(opens sec.gov)
Feb 104
ENANTA PHARMACEUTICALS INC0000908662-14-000057
SEC(opens sec.gov)
Dec 134
ENANTA PHARMACEUTICALS INC0000908662-13-000324
SEC(opens sec.gov)
Oct 314
Sorrento Therapeutics, Inc.0001181431-13-055943
SEC(opens sec.gov)
Jun 134
SEQUENOM INC0001321466-13-000064
SEC(opens sec.gov)
Mar 284
ENANTA PHARMACEUTICALS INC0000908662-13-000163
SEC(opens sec.gov)
Mar 224
ENANTA PHARMACEUTICALS INC0000908662-13-000145
SEC(opens sec.gov)
Jan 34
SEQUENOM INC0001321466-13-000008
SEC(opens sec.gov)

Companies

Address

3595 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121